NCT07171242 Shanghai Prospective Registry Study of Ischemic Stroke
| NCT ID | NCT07171242 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Qiang Dong |
| Condition | Ischemic Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 15,000 participants |
| Start Date | 2024-12-01 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 15,000 participants in total. It began in 2024-12-01 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to conduct a prospective cohort study on patients with imaging-confirmed ischemic stroke based on the 4S database. The primary objectives are to investigate the incidence, clinical characteristics, risk factors, and pathophysiological mechanisms of young-onset stroke, as well as to analyze the evolving trends in the etiology of young-onset stroke in the Shanghai region over recent years. This includes examining the roles of traditional risk factors (such as hypertension and diabetes) and emerging factors (such as air pollution and lifestyle changes), and exploring the associations between these factors and patient outcomes. Additionally, the study will analyze the association between reperfusion therapies such as intravenous thrombolysis, acute-phase management, and secondary prevention with clinical outcomes. Finally, it will delve into the screening, treatment, and challenges associated with genetic young stroke patients with Farby syndrome, providing comprehensive information for regional stroke prevention and control strategies targeting young stroke patients.
Eligibility Criteria
Inclusion Criteria: 1. Patients aged 18 years or older diagnosed with acute or subacute ischemic stroke 2. The diagnosis of stroke must be confirmed through clinical assessment and imaging examinations 3. In cases where imaging examinations are negative or unavailable, the clinical diagnosis of stroke must be confirmed by an experienced neurologist. (4)Patients must sign an informed consent form agreeing to the collection of information. Exclusion Criteria: 1. The amount of missing data exceeds 40% of the data to be entered; 2. After enrollment, it is discovered that the study participant does not meet the inclusion criteria or meets any of the exclusion criteria; 3. Missing persons
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07171242 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07171242 currently recruiting?
Yes, NCT07171242 is actively recruiting participants. Contact the research team at qiang_dong163@163.com for enrollment information.
Where is the NCT07171242 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT07171242 clinical trial?
NCT07171242 is sponsored by Qiang Dong. The trial plans to enroll 15,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.